argenx at Antibody Engineering 2026
Dec 13–16, 2026 San Diego, CA ~900 attendees Website
argenx takes part in 1 session at Antibody Engineering 2026 in San Diego. Its program centers on an engineered antibody approach that lowers levels of every IgG subclass. The work points to uses outside cancer, in line with argenx's focus on autoimmune disease.
| Organization | Antibody Engineering 2026 Attendance |
|---|---|
Immunology company developing antibody-based medicines for autoimmune diseases, with marketed FcRn-blocking therapy. | Talk Wed Dec 16 4:45pm–5:15pm A Novel Antibody Approach to Pan-subclass IgG Reduction An antibody that sweeps up and destroys every subtype of the main antibody class in blood, for diseases caused by self-attacking antibodies. Beyond oncology |
Find decision makers at argenx
Tell us what you sell and we’ll find the people at argenx most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by Antibody Engineering & Therapeutics, its organizers or The Antibody Society. Submit a correction